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ABSTRACT
Background: Knowledge regarding characteristics and
transmission of Neisseria gonorrhoeae, Chlamydia
trachomatis and Mycoplasma genitalium and antibiotic
resistance in N gonorrhoeae in Guinea-Bissau, West
Africa, is entirely lacking.
Objectives: To characterise N gonorrhoeae,
C trachomatis and M genitalium samples from Guinea-
Bissau and to deﬁne bacterial populations, possible
transmission chains and for N gonorrhoeae spread of
antibiotic-resistant isolates.
Design: Prospective cohort study.
Setting: Two sexual health and family planning clinics,
Bissau, Guinea-Bissau.
Participants: Positive samples from 711 women and
27 men.
Material and methods: Positive samples for
N gonorrhoeae (n¼31), C trachomatis (n¼60) and
M genitalium (n¼30) were examined. The gonococcal
isolates were characterised with antibiograms, serovar
determination and N gonorrhoeae multiantigen
sequence typing (NG-MAST). The C trachomatis ompA
gene and the M genitalium mgpB gene were sequenced,
and phylogenetic analyses were performed.
Results: For N gonorrhoeae, the levels of resistance
(intermediate susceptibility) to ciproﬂoxacin,
erythromycin, rifampicin, ampicillin, tetracycline,
penicillin G and cefuroxime were 10% (0%), 6%
(10%), 13% (10%), 68% (0%), 74% (0%), 68%
(16%) and 0% (84%), respectively. All isolates were
susceptible to ceﬁxime, ceftriaxone, spectinomycin
and azithromycin, and the minimum inhibitory
concentrations of kanamycin (range: 8e32 mg/l) and
gentamicin (range: 0.75e6 mg/l) were low (no
resistance breakpoints exist for these antimicrobials).
19 NG-MAST sequence types (STs) (84% novel STs)
were identiﬁed. Phylogenetic analysis of the
C trachomatis ompA gene revealed genovar G as most
prevalent (37%), followed by genovar D (19%). 23
mgpB STs were found among the M genitalium
isolates, and 67% of isolates had unique STs.
Conclusions: The diversity among the sexually
transmitted infection (STI) pathogens may be
associated with suboptimal diagnostics, contact
tracing, case reporting and epidemiological
surveillance. In Guinea-Bissau, additional STI studies
are vital to estimate the STI burden and form the basis
for a national sexual health strategy for prevention,
diagnosis and surveillance of STIs.
INTRODUCTION
Guinea-Bissau, West Africa, is classiﬁed as the
sixth least developed country in the world.
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ARTICLE SUMMARY
Article focus
- Knowledge regarding characteristics and trans-
mission of Neisseria gonorrhoeae, Chlamydia
trachomatis and Mycoplasma genitalium and
antibiotic resistance in N gonorrhoeae in
Guinea-Bissau, West Africa, is entirely lacking.
- We aimed to phenotypically and genetically
characterise N gonorrhoeae, and genetically char-
acterise C trachomatis and M genitalium samples
from women attending two sexual health clinics in
Bissau, Guinea-Bissau and to deﬁne the bacterial
populations, possible transmission chains and for
N gonorrhoeae also to deﬁne the presence and
spread of antibiotic-resistant isolates from women
and additionally a group of symptomatic men.
Key messages
- In Guinea-Bissau, N gonorrhoeae isolates
displayed high level of resistance to traditional
gonorrhoea antimicrobials but have remained
susceptible to extended-spectrum cephalospo-
rins, spectinomycin and azithromycin.
- Genovar G, D and F were the most prevalent
C trachomatis genovars, the usually most
common genovar among heterosexuals, that is,
genovar E, was rare.
- The diversity among the bacterial STI pathogens
may be associated with suboptimal diagnostics,
contact tracing, case reporting and epidemiolog-
ical surveillance. Additional studies are vital to
estimate the STI burden and form the basis for
a national sexual health strategy for prevention,
diagnosis and surveillance.
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Open Access ResearchThe total number of inhabitants is about 1.6 million with
250000e300000 living in the capital city Bissau. The
healthcare system is exceedingly limited and highly
centralised to Bissau.
Guinea-Bissau has previously presented the highest
HIV-2 prevalence globally. However, after the civil war in
1998e1999, the HIV-2 prevalence has decreased and in
contrast the HIV-1 prevalence has increased.
2 HIV sero-
positive individuals have shown a higher prevalence of
bacterial sexually transmitted infections (STIs), and
presence of several bacterial STIs has been associated
with a facilitated HIV acquisition and transmission.
23
Present knowledge regarding the prevalence of
bacterial STIs in Guinea-Bissau is highly limited. Studies
from 2001 to 2002 described a prevalence of Neisseria
gonorrhoeae and Chlamydia trachomatis infections of 17%
and 4%, respectively, among women with vaginal
discharge, and in pregnant women, the prevalence rate
for Mycoplasma genitalium was 6.2%.
4 5 In a recent study
of women attending two sexual health clinics in Bissau,
due to urogenital problems, the prevalence of N gonor-
rhoeae, C trachomatis and M genitalium infections was
1.3%, 12.6% and 7.7%, respectively.
2
In Guinea-Bissau, in routine, the laboratory diagnosis of
N gonorrhoeae is mainly based on microscopy of Gram
stained urogenital smears, no appropriate diagnostics is
performed for Ct r a c h o m a t i sand M genitalium and no
previous study has phenotypically and genetically typed
strains of these bacterial STIs. Consequently, knowledge
regarding the characteristics and transmission of circu-
lating strains of Ng o n o r r h o e a e(including antibiotic resis-
tance), Ct r a c h o m a t i sand M genitalium is entirely lacking.
The aims of the present study were to phenotypically and
genetically characterise N gonorrhoeae and genetically char-
acterise C trachomatis and M genitalium samples from
women attending two sexual health clinics in Bissau,
Guinea-Bissau and to deﬁne the bacterial populations,
possible transmission chains and for N gonorrhoeae to deﬁne
the presence and spread of antibiotic-resistant isolates from
women and additionally a group of symptomatic men.
MATERIALS AND METHODS
Study population
The current study further examined specimens obtained
in a previous prevalence study of 711 women attending
two sexual health and family planning clinics (Aguibef
Clinic and Centro Materno-Infantil Clinic) for urogen-
ital problems in Bissau, Guinea-Bissau. All women
visiting the clinics from February 2006 to January 2008
were offered participation.
2 Sixty samples analysed
positive for C trachomatis, 30 analysed positive for
M genitalium and four culture-positive N gonorrhoeae
isolates were available for further examination. In addi-
tion, 27 N gonorrhoeae isolates cultured, during February
2006 to January 2008, from men (n¼27) with urogenital
symptoms at the National Public Health Laboratory,
Bissau, Guinea-Bissau, were included.
Laboratory characterisation
All 31 N gonorrhoeae isolates were initially cultured and
preserved at  708C as previously described.
2 6 Brieﬂy,
endocervical (women) or urethral (men) samples were
cultured within 5 h on modiﬁed ThayereMartin
medium for 48e72 h. Species conﬁrmation was based
on identiﬁcation of rapid oxidase production, Gram--
negative diplococci in microscopy and use of PhadeBact
Monoclonal GC Test (Bactus, Stockholm, Sweden).
2
Antibiotic susceptibility testing, serovar determination,
DNA isolation and genetic characterisation by means of
N gonorrhoeae multiantigen sequence typing (NG-MAST)
were performed as previously described.
7
C trachomatis and M genitalium specimens were initially
diagnosed with PCR as previously described.
2 Brieﬂy,
DNA was isolated from endocervical samples using the
E.Z.N.A. Tissue DNA Kit (Omega Bio-tek, Doraville,
Georgia, USA), and conventional PCRs, using previously
described primers, were performed for diagnosis of
M genitalium (target: 16S rRNA gene and, for conﬁrma-
tion, MgPa adhesion (mgpB) gene) and C trachomatis
(target: ompA gene).
2
For typing of C trachomatis, the ompA gene was PCR
ampliﬁed, the PCR product was puriﬁed and subse-
quently sequenced and ﬁnally about 1100 nucleotides of
the ompA sequence was used in a phylogenetic analysis
for determination of the genovar, as previously
described.
8
For typing of M genitalium, the mgpB gene was PCR
ampliﬁed and sequenced as previously described,
9 with
some modiﬁcations. These modiﬁcations included use
of 0.4 mM of each of the primers MgPa-1 and MgPa-3
(Scandinavian Gene Synthesis AB, Ko ¨ping, Sweden) and
2.0 U of AmpliTaq Gold DNA polymerase (PE Biosystems,
Branchburg, New Jersey, USA). The PCR programme
consisted of an AmpliTaq Gold DNA polymerase activa-
tion step at 948C for 10 min, followed by 40 sequential
cycles of 948C for 30 s, 608C for 30 s, 728C for 1 min and
ﬁnally an extension step of 728C for 5 min. All PCR
products were stored at 48C prior to puriﬁcation. The
PCR products were puriﬁed using the High Pure PCR
Product Puriﬁcation Kit (Boehringer Mannheim, Indi-
anapolis, Indiana, USA) according to the manufacturer’s
instructions. The PCR products were sequenced with the
same primers as used in the PCR, utilising the ABI
PRISM BigDye Terminator Cycle Sequencing Ready
ARTICLE SUMMARY
Strengths and limitations of this study
- This is the ﬁrst time N gonorrhoeae, C trachomatis and
M genitalium samples from Bissau, Guinea-Bissau, have been
phenotypically and genetically characterised to deﬁne the
bacterial populations, possible transmission chains and
antibiotic resistance in N gonorrhoeae.
- The study sample was relatively small, and in this setting, it is
difﬁcult to perform appropriate sample transportation and
storage, as well as optimised diagnostics, which may have
resulted in that true-positive samples were lost.
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Characterisation of bacterial STIs in Guinea-BissauReaction v3.1 kit (Applied Biosystems, Warrington, UK)
and an ABI Sequencer 3120 (Applied Biosystems), in
accordance with the instructions from the manufacturer.
Phylogenetic analysis was performed in the same way as
for C trachomatis.
8
RESULTS
Characterisation of N gonorrhoeae
The results of the antibiotic susceptibility testing of all the
N gonorrhoeae isolates (n¼31) are presented in table 1.
Brieﬂy, the levels of resistance (intermediate suscepti-
bility) to ciproﬂoxacin, erythromycin, rifampicin, ampi-
cillin, tetracycline, penicillin G and cefuroxime were 10%
(0%), 6% (10%), 13% (10%), 68% (0%), 74% (0%), 68%
(16%) and 0% (84%), respectively. Twenty-one (68%) of
the 31 isolates were b-lactamase producing. All isolates
were susceptible to ceﬁxime, ceftriaxone, spectinomycin
and azithromycin, and the minimum inhibitory concen-
trations (MICs) of kanamycin (8e32 mg/l) and genta-
micin (0.75e6 mg/l) were low (no resistance breakpoints
exist for these antimicrobials) (table 1).
All the N gonorrhoeae isolates were serotypeable, 20
(64.5%) were determined as serogroup WII/III
(PorB1b). These isolates were assigned four different
serovars: Bropt (n¼16), Bropst (n¼2), Bpyvut (n¼1)
and Brpyvust (n¼1). The remaining 11 (35.5%) isolates
were determined as serogroup WI (PorB1a). These
isolates were assigned two different Ph serovars: Arst
(n¼10) and Arost (n¼1).
The isolates were assigned to 19 different NG-MAST
sequence types (STs), of which 16 (84%) have not been
previously described (table 2). The ST3176 (n¼7),
ST783 (n¼5) and ST3182 (n¼3) were the most preva-
lent STs. Of these, ST783 has been described in UK,
while ST3176 and ST3182 were not earlier described.
The remaining 16 isolates were all of different sequence
types. Of these, ST1318 has been described in isolates
from Arkhangelsk, Russia, Scotland and Canada, and
ST2187 in Australia (NG-MAST website: http://www.ng-
mast.net).
Notable, the three ciproﬂoxacin-resistant isolates (all
displaying MIC$1.5 mg/l) were assigned three different
STs (ST3181, ST3184 and ST3186) and two different
serovars (Bropst, n¼2, and Brpyvust, n¼1).
Characterisation of C trachomatis
Phylogenetic analysis of the ompA gene sequences from
60 C trachomatis samples revealed that the most frequent
genovar was G (22 isolates, 37%), followed by D (19%),
F (17%), I (14%), E (5%), J (5%), H (1.5%) and K
(1.5%) (table 2). Accordingly, genovar E that is the most
prevalent genovar followed by genovar F and genovar D
in studies from other settings globally was relatively
rare.
10e19
Characterisation of M genitalium
A total of 23 mgpB STs were found among the 30
M genitalium samples. Only three clusters, one with four
isolates (‘ST1’) and two containing three isolates (‘ST2’
and ‘ST3’), were detected (ﬁgure 1, table 2). The
remaining sequence types (‘ST4’e‘ST23’) were only
represented by single isolates.
DISCUSSION
In the present study, bacterial STIs in Guinea-Bissau
were for the ﬁrst time characterised, phenotypically and
genetically, demonstrating highly divergent populations
of N gonorrhoeae and M genitalium, and compared with
other settings worldwide an unusual genovar distribu-
tion for C trachomatis. However, due to the limited
number of samples examined, all results need to be
interpreted with caution.
The genetic characterisation of the 31 N gonorrhoeae
isolates showed a total of 19 different NG-MAST STs, and
only three (16%) of these STs have been previously
Table 1 Antibiotic susceptibility of 31 Neisseria gonorrhoeae isolates from Bissau, Guinea-Bissau
Antibiotic (breakpoints) Susceptible (%) Intermediate (%) Resistant (%)
Penicillin G (S#0.064/R>1.0)* 5 (16) 5 (16) 21 (68)y
Ampicillin (S#0.125/R>3.0) 10 (32) 0 21 (68)y
Ceﬁxime (S#0.125/R>0.125)* 31 (100) 0 0
Ceftriaxone (S#0.125/R>0.125)* 31 (100) 0 0
Cefuroxime (S#0.064/R>1.0) 5 (16) 26 (84) 0
Azithromycin (S#0.25/R>0.5)* 31 (100) 0 0
Erythromycin (S#0.25/R>0.5) 26 (84) 3 (10) 2 (6)
Ciproﬂoxacin (S#0.032/R>0.064)* 28 (90) 0 3 (10)
Spectinomycin (S#64/R>64)* 31 (100) 0 0
Tetracycline (S#0.5/R>1.0)* 8 (26) 0 23 (74)
Rifampicin (S#0.125/R>32) 24 (77) 3 (10) 4 (13)
Gentamicin MIC range: 0.75e6 mg/l
Kanamycin MIC range: 8e32 mg/l
*Breakpoints (for susceptible (S#x mg/l) and resistant (R>y mg/l)) according to the European Committee on Antimicrobial Susceptibility Testing
(EUCAST; http://www.eucast.org) were used, when available.
yAll were b-lactamase producing.
MIC, minimum inhibitory concentration.
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website: http://www.ng-mast.net). Accordingly, ST783
has been described in UK; ST1318 in Russia,
20 Scotland
and Canada and ST2187 in Australia (NG-MASTwebsite:
http://www.ng-mast.net). The ST3176 (n¼7), ST783
(n¼5) and ST3182 (n¼3), were the most prevalent STs,
while the remaining 16 STs were represented by single
isolates. The high number of STs represented by single
isolates could be a consequence of suboptimal diagnos-
tics, limited and biased sampling, ineffective or non-
existing contact tracing, local and recent emergence of
new STs and import of strains.
The serological characterisation divided the isolates
into 20 (64.5%) serogroup WII/III (PorB1b) isolates
and 11 (35.5%) serogroup WI (PorB1a) isolates. The
proportion of serogroup WI (PorB1a) isolates was rela-
tively high compared with, for example, Sweden with
26% WI (PorB1a) isolates reported in 2009,
21 Italy with
4.1% WI (PorB1a) isolates in 2008
22 and Russia with 26%
WI (PorB1a) isolates in 2007
20 but lower than described
from India with 46.7% WI (PorB1a) isolates in 2007.
23
The isolates from Guinea-Bissau were further divided
into six different Ph serovars.
As clearly shown, the genetic characterisation (19 NG-
MAST STs) had a substantially higher discriminative
power than the serovar determination (six serovars).
Furthermore, no NG-MAST STs were further subdivided
using serovars determination. Accordingly, genetic
typing should preferably be used for epidemiological
purposes, especially in geographical areas that comprise
highly heterogeneous N gonorrhoeae populations.
The antibiotic susceptibility testing displayed relatively
high levels of resistance and/or intermediate suscepti-
bility to most antibiotics previously recommended as ﬁrst
line for treatment of gonorrhoea, for example, penicil-
lins, tetracycline, erythromycin and cefuroxime.
However, due to the low number of gonococcal isolates
(n¼31) examined in the present study, the resistance
levels need to be interpreted with caution. The resis-
tance level to ciproﬂoxacin (10%) was relatively low.
Nevertheless, at the time of collection of the gonococcal
isolates (2006e2008), similar low levels of resistance to
ciproﬂoxacin were shown also in other studies from
African countries, for example, from Malawi
Mozambique, Central African Republic and
Madagascar.
24e26 These ciproﬂoxacin resistance levels
were substantially lower than the levels described from
many other countries worldwide, where it is now a fear
that gonorrhoea may become untreatable in certain
circumstances.
27 28 However, more recent studies
from African countries such as Kenya and South Africa
have shown a rapidly increasing resistance to cipro-
ﬂoxacin.
29 30 The slower pace of emerging ciproﬂoxacin
resistance in Guinea-Bissau and several other African
countries strains may reﬂect the fact that ﬂuo-
roquinolones for treatment of gonorrhoea were not
widely used as early in Guinea-Bissau (as well as several
other African countries), as in other settings worldwide.
Fortunately, all isolates were susceptible to ceﬁxime,
ceftriaxone, azithromycin and spectinomycin and had
low MICs of gentamicin and kanamycin. Nevertheless,
due to the high and increasing resistance levels to many
of these antibiotics worldwide, it is essential to enhance
the gonococcal antibiotic susceptibility surveillance in
African countries as well as globally. In some settings, the
resistance levels to previously recommended ﬁrst-line
antibiotics may have remained low and these antibiotics
might be valuable to continue to use for treatment of
gonorrhoea in these speciﬁc settings. Nevertheless, that
type of recommendation needs to be supported
by sufﬁcient local, appropriate and quality-assured
antibiotic susceptibility data.
The phylogenetic analysis of ompA gene sequences in
the 60 C trachomatis samples revealed that genovar G
(37%) was the most frequent genovar, followed by
genovar D (19%) and genovar F (17%). Studies from
other settings globally, from 2000 to 2011, have shown
that genovar E is the most prevalent followed by genovar
F and genovar D.
10e19 Furthermore, a longitudinal study
over a 9-year period (1988e1996) in Seattle showed
similar serovar distribution as reported from other parts
of the world and also a stability in the serovar groups
over time, except for the more rare serovars I and K.
11
Genovar G, which was the most frequent genovar
Table 2 Distribution of different genotypes of Chlamydia trachomatis, Mycoplasma genitalium and Neisseria gonorrhoeae
among infected women in Guinea-Bissau
Chlamydia trachomatis
(genovar, n[60)*
Mycoplasma genitalium
(sequential numbers, n[30)y
Neisseria gonorrhoeae
(NG-MAST, n[31)
G (37%) 1 (13%) ST3176 (23%)z
D (19%) 2 (10%) ST783 (16%)
F (17%) 3 (10%) ST3182 (10%)z
I (14%) 4e23 (single isolates 67%) ST2187 (single isolate, 3%)
E (5%) ST1318 (single isolate, 3%)
J (5%) ST3177e81 (single isolates, 13%)z
H (1.5%) ST3183e89 (single isolates, 26%)z
K (1.5%) ST3376e77 (single isolates, 6%)z
*Based on ompA genotyping.
yBased on sequencing of the M genitalium MgPa adhesion (mgpB) gene.
zNovel NG-MAST STs.
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Characterisation of bacterial STIs in Guinea-Bissauamong women in Guinea-Bissau, has in other settings
worldwide been the most frequently detected genovar in
infections in men who have sex with men.
12 17e19 This
unusual C trachomatis genovar distribution among
women in Guinea-Bissau may reﬂect the limited sample
size, although it can also indicate a local domestic
transmission with little importation of strains from
abroad.
The ompA sequences were also highly conserved within
the genovars. Accordingly, insufﬁcient epidemiological
resolution is obtained by ompA sequencing, and novel
molecular methods for typing of C trachomatis, such as
multiple loci variable number of tandem repeats
(VNTR) analysis (MLVA) and multilocus sequence
typing (MLST), which both show a substantially higher
discriminatory power, are vital.
31
Among the 30 M genitalium samples, 67% of the mgpB
STs were only represented by single isolates. Only three
small clusters, two containing three isolates and one
containing four isolates, were identiﬁed. This high
genetic diversity may suggest that M genitalium is
endemic in Bissau and that infection is not due to the
distribution of a single strain.
Bacterial STIs are public health problems causing
substantial morbidity and economical cost. Furthermore,
if undetected and untreated, many bacterial STIs are
associated with severe complications and sequelae such
as PID, ectopic pregnancy, infertility and facilitated
Figure 1 Phylogenetic tree
based on a 238 nucleotide
sequence of the Mycoplasma
genitalium MgPa adhesin gene
(mgpB) in 30 samples from
Bissau, Guinea-Bissau. The same
sequence from the M genitalium
reference strain G37
T
(DQ248092) was used for rooting
the tree.
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inadequate detection and/or treatment of these patho-
gens inevitably contribute also to further transmission of
the STIs. Despite that the present study did not show any
alarming tendency of N gonorrhoeae strains resistant to
extended-spectrum cephalosporins, macrolides and
spectinomycin, in Bissau, Guinea-Bissau, the rapidly
increasing resistance to also these antibiotics worldwide
makes it important to introduce quality-assured gono-
coccal antibiotic resistance surveillance also in Guinea-
Bissau and in general in West Africa. Furthermore, due
to the high prevalence of HIV in many of the West
African countries and the fact that several of these
bacterial STIs also facilitate the acquisition and trans-
mission of HIV, more prevalence studies of bacterial STIs
as well as national and regional strategies for prevention
and control of bacterial STIs in this region are crucial to
implement.
In conclusion, the high diversity of N gonorrhoeae, C
trachomatis and M genitalium strains in Bissau, Guinea-
Bissau, may be associated with suboptimal diagnostics,
contact tracing, case reporting and epidemiological
surveillance. Overall, it is exceedingly difﬁcult to esti-
mate the true burden, distribution and characteristics of
STIs in Guinea-Bissau, as well as in many other countries
in West Africa. Accordingly, additional studies in other
population groups, and in other geographical areas, are
crucial to perform in Guinea-Bissau and other countries
in the region. The present study compiled with such
future studies may form the basis for a national sexual
health strategy for prevention, diagnosis and surveillance
of STIs in Guinea-Bissau.
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